Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
7,844 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00075218 | A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) | completed | Phase 3 | 361 | PfizerINDUSTRY | 11 | Sep 28, 2009 | clinicaltrials |
| NCT00321308 | Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 36 | PfizerINDUSTRY | 3 | Sep 28, 2009 | clinicaltrials |
| NCT00799799 |
| Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells |
| unknown |
| Phase 1 |
| 15 |
| University of BolognaOTHER |
| 1 |
| Sep 24, 2009 |
| clinicaltrials |
| NCT00501098 | Prophylaxis of Fungal Invasive Infections in Leukemia(PROFIL-C) | completed | Phase 2 | 100 | Northern Italy Leukemia GroupOTHER | 1 | Sep 22, 2009 | clinicaltrials |
| NCT00982098 | Prevention of Urinary Incontinence After Prostatectomy | unknown | N/A | 110 | Azienda Ospedaliero Universitaria Maggiore della CaritaOTHER | 1 | Sep 22, 2009 | clinicaltrials |
| NCT00354822 | Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.(Z0105) | terminated | Phase 2 | 25 | A.O. Ospedale Papa Giovanni XXIIIOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00979160 | Evaluation of Response of Dasatinib to Treat Mastocytosis | unknown | Phase 2 | 30 | Federico II UniversityOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00137449 | Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor | completed | Phase 2 | 60 | PfizerINDUSTRY | 3 | Sep 15, 2009 | clinicaltrials |
| NCT00276926 | Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias | unknown | Phase 2 | — | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00797810 | Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults | unknown | Phase 4 | 25 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00801580 | My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia | unknown | Phase 2 | 3 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00928603 | Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment | unknown | Phase 1 | 100 | Università Vita-Salute San RaffaeleOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00965627 | Biology of Thymic Tumors | completed | — | 134 | Istituto Clinico HumanitasOTHER | 1 | Aug 28, 2009 | clinicaltrials |
| NCT00963794 | Diagnosis of Rectal Cancer by Electromagnetic Device | completed | N/A | 442 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 24, 2009 | clinicaltrials |
| NCT00960609 | Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound Study | completed | — | — | University of MilanOTHER | 1 | Aug 18, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00510939 | Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia(HEMOS AML 0106) | unknown | Phase 2 | 72 | University of BolognaOTHER | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00598624 | Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)(AlloTreo) | unknown | Phase 2 | 175 | IRCCS San RaffaeleOTHER | 1 | Aug 11, 2009 | clinicaltrials |
| NCT00954135 | Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients | unknown | Phase 2 | 190 | University of Turin, ItalyOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | completed | Phase 2 | 29 | University of Turin, ItalyOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00382759 | Nonmyeloablative Stem Cell Transplant in Elderly | completed | Phase 2 / Phase 3 | 50 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00786331 | Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC | unknown | Phase 2 | 230 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00610792 | Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens | withdrawn | Phase 2 | 91 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | Jul 14, 2009 | clinicaltrials |
| NCT00936572 | Probiotics In Colorectal Cancer Patients | completed | Phase 2 | 35 | University of Milano BicoccaOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00911443 | Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma | completed | Phase 2 | 488 | sigma-tau i.f.r. S.p.A.INDUSTRY | 8 | Jul 9, 2009 | clinicaltrials |
| NCT00934557 | Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation(ATG FRES) | unknown | Phase 3 | 42 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00234442 | Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer | terminated | Phase 2 | 47 | AstraZenecaINDUSTRY | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00842998 | Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer(HERLAP) | unknown | Phase 2 | 120 | Azienda Ospedaliera Ordine Mauriziano di TorinoOTHER | 1 | Jun 26, 2009 | clinicaltrials |
| NCT00044538 | Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 102 | BayerINDUSTRY | 6 | Jun 22, 2009 | clinicaltrials |
| NCT00910078 | Serum Free Light Change in Multiple Myeloma | completed | — | — | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | May 29, 2009 | clinicaltrials |
| NCT00452140 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 5 | May 19, 2009 | clinicaltrials |
| NCT00307866 | Identification of Hepatic Lesions | completed | Phase 3 | 218 | BayerINDUSTRY | 1 | May 18, 2009 | clinicaltrials |
| NCT00894725 | Laparoscopic Versus Open Left Colonic Resection | completed | Phase 3 | 268 | Università Vita-Salute San RaffaeleOTHER | 1 | May 7, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | completed | Phase 3 | 448 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00256711 | Phase II Iressa Versus Vinorelbine (INVITE) | completed | Phase 2 | 192 | AstraZenecaINDUSTRY | 10 | Apr 23, 2009 | clinicaltrials |
| NCT00275210 | MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer | completed | Phase 3 | 2,246 | SanofiINDUSTRY | 19 | Apr 20, 2009 | clinicaltrials |
| NCT00883454 | Estimation of Functional Liver Reserve Using Cholinesterases | completed | — | 181 | University of MilanOTHER | 1 | Apr 17, 2009 | clinicaltrials |
| NCT00880945 | Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions | unknown | — | 40 | Azienda Ospedaliero Universitaria Maggiore della CaritaOTHER | 1 | Apr 14, 2009 | clinicaltrials |
| NCT00876148 | Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting | completed | — | — | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Apr 6, 2009 | clinicaltrials |
| NCT00294996 | Trial of Myocet in Metastatic Breast Cancer | unknown | Phase 3 | 363 | Sopherion TherapeuticsINDUSTRY | 11 | Mar 31, 2009 | clinicaltrials |
| NCT00866203 | HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy | completed | Phase 3 | 441 | Gruppo Italiano Studio LinfomiOTHER | 1 | Mar 20, 2009 | clinicaltrials |
| NCT00859001 | Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy(FM+R-Z) | completed | Phase 2 | 55 | University of BolognaOTHER | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00450645 | Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis(Cancer-DACUS) | unknown | Phase 4 | 300 | Azienda Ospedaliera Universitaria PoliclinicoOTHER | 1 | Mar 4, 2009 | clinicaltrials |
| NCT00609401 | Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)(ROSORC) | completed | Phase 2 | 90 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)(P2) | completed | Phase 2 | 46 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00619996 | Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer(P1) | completed | Phase 2 | 43 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00850512 | Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy(CHOP21+R-Z) | completed | Phase 2 | 55 | University of BolognaOTHER | 1 | Feb 25, 2009 | clinicaltrials |
| NCT00786110 | Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients(PAXO) | unknown | Phase 2 | 30 | University of Turin, ItalyOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00531973 | A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging(LITE) | unknown | Phase 4 | 80 | Catholic University, ItalyOTHER | 1 | Feb 18, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials